Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Receives $22.29 Average Price Target from Brokerages
Shares of Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Get Free Report) have been assigned a consensus rating of “Buy” from the nine research firms that are covering the firm, Marketbeat reports. Eight analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12 month […]
Shares of Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Get Free Report) have been assigned a consensus rating of “Buy” from the nine research firms that are covering the firm, Marketbeat reports. Eight analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12 month […]
